This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics US
December 15 - 18, 2024
Marriott Marquis San DiegoLive In-Person Event: December 15 - 18, 2024

Laura Ranum, Ph.D.
Director, Center for NeuroGenetics at University of Florida
Speaker

Profile

Dr. Laura P.W. Ranum, is the Director of the Center for Neurogenetics and the Kitzman Family Professor of Molecular Genetics and Microbiology at the University of Florida. In 2011, her lab discovered that novel category of proteins are produced from repeat expansion mutations without canonical AUG-initiation codons. These toxic, repeat-associated, non-AUG (RAN) proteins have been found in a growing number of neurodegenerative diseases including Huntington’s disease, amyotrophic lateral sclerosis, frontotemporal dementia, and ataxia. Recent data she will present show RAN proteins are a common type of pathology found in Alzheimer’s disease. Additionally, her group has developed a novel method to clone repeat expansion mutations directly from patient DNA. Mechanistic insights from her recent work have identified novel therapeutic strategies to treat RAN protein disorders.

Agenda Sessions

  • AAV-based anti-RAN antibody therapy for C9orf72 ALS/FTD

    10:30am